In the year and a half since its launch, 988 — the country’s easy-to-remember, three-digit suicide and crisis hotline — has received about 8.1 million calls, texts, and chats.
Cybin gears up for registrational trial of psilocybin analog in major depression after PhII success
Cybin’s psychedelic-inspired drug candidate has met the primary endpoint of its mid-stage test in major depressive disorder (MDD), sparking preparations for a Phase III trial